National Health Investors, Inc. (NHI) Upgraded by Zacks Investment Research to “Buy”
Zacks Investment Research upgraded shares of National Health Investors, Inc. (NYSE:NHI) from a hold rating to a buy rating in a research note issued to investors on Wednesday. Zacks Investment Research currently has $89.00 price objective on the real estate investment trust’s stock.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
Several other equities analysts have also issued reports on the company. BidaskClub raised National Health Investors from a sell rating to a hold rating in a research note on Thursday, August 17th. Mizuho reissued a neutral rating on shares of National Health Investors in a research note on Wednesday, June 28th. Stifel Nicolaus boosted their price target on National Health Investors from $80.00 to $82.00 and gave the company a buy rating in a research note on Wednesday, June 21st. ValuEngine lowered National Health Investors from a buy rating to a hold rating in a research note on Tuesday, June 13th. Finally, Bank of America Corporation lowered National Health Investors from a neutral rating to an underperform rating and set a $76.00 price target on the stock. in a research note on Monday, May 22nd. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. National Health Investors currently has a consensus rating of Hold and an average price target of $81.20.
National Health Investors (NYSE:NHI) opened at 79.61 on Wednesday. The stock has a 50 day moving average of $77.39 and a 200 day moving average of $75.39. The stock has a market capitalization of $3.26 billion, a P/E ratio of 20.44 and a beta of 0.56. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53.
National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. During the same period last year, the firm posted $1.22 earnings per share. National Health Investors’s quarterly revenue was up 14.1% compared to the same quarter last year. On average, equities research analysts forecast that National Health Investors will post $3.88 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is 97.69%.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.19% of the stock is owned by corporate insiders.
Several institutional investors have recently modified their holdings of the company. Carroll Financial Associates Inc. purchased a new position in shares of National Health Investors during the second quarter worth $158,000. Quantbot Technologies LP purchased a new position in shares of National Health Investors during the first quarter worth $201,000. Yorktown Management & Research Co Inc purchased a new position in shares of National Health Investors during the second quarter worth $214,000. Allegis Investment Advisors LLC purchased a new position in shares of National Health Investors during the second quarter worth $216,000. Finally, Daiwa Securities Group Inc. raised its position in shares of National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after buying an additional 55 shares during the last quarter. 70.58% of the stock is currently owned by institutional investors.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.